Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Douce

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
FEMS Immunology and Medical Microbiology|June 1, 1993
The development of oral vaccines based on live attenuated Salmonella strainsS Chatfield, M Roberts, P Londono, et al.
Infection and Immunity|February 26, 2000
Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccinesM Sydenham, G Douce, F Bowe, et al.
Infection and Immunity|May 25, 1999
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel diseaseL M Higgins, G Frankel, G Douce, et al.
Vaccine|December 15, 2000
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanusR Stratford, G Douce, L Zhang-Barber, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 13, 2012
Review of invasive cervical cancers and uptake of disclosure of results: an audit of procedures and responseI Prabakar, E L Moss, G Douce, et al.
Vaccine|June 28, 2000
Intranasal vaccination of mice against infection with Mycobacterium tuberculosisG Falero-Diaz, S Challacombe, D Banerjee, et al.
Developments in Biological Standardization|April 29, 1998
Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunizationM T De Magistris, M Pizza, G Douce, et al.
International Journal of Medical Microbiology : IJMM|December 9, 2000
LTK63 and LTR72, two mucosal adjuvants ready for clinical trialsM Pizza, M M Giuliani, M R Fontana, et al.
Infection and Immunity|August 24, 1999
Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvantsG Douce, V Giannelli, M Pizza, et al.
Vaccine|July 31, 1998
Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coliG Douce, M M Giuliani, V Giannelli, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
FEMS Immunology and Medical Microbiology|June 1, 1993
The development of oral vaccines based on live attenuated Salmonella strainsS Chatfield, M Roberts, P Londono, et al.
Infection and Immunity|February 26, 2000
Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccinesM Sydenham, G Douce, F Bowe, et al.
Infection and Immunity|May 25, 1999
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel diseaseL M Higgins, G Frankel, G Douce, et al.
Vaccine|December 15, 2000
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanusR Stratford, G Douce, L Zhang-Barber, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 13, 2012
Review of invasive cervical cancers and uptake of disclosure of results: an audit of procedures and responseI Prabakar, E L Moss, G Douce, et al.
Vaccine|June 28, 2000
Intranasal vaccination of mice against infection with Mycobacterium tuberculosisG Falero-Diaz, S Challacombe, D Banerjee, et al.
Developments in Biological Standardization|April 29, 1998
Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunizationM T De Magistris, M Pizza, G Douce, et al.
International Journal of Medical Microbiology : IJMM|December 9, 2000
LTK63 and LTR72, two mucosal adjuvants ready for clinical trialsM Pizza, M M Giuliani, M R Fontana, et al.
Infection and Immunity|August 24, 1999
Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvantsG Douce, V Giannelli, M Pizza, et al.
Vaccine|July 31, 1998
Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coliG Douce, M M Giuliani, V Giannelli, et al.
Pageof 4